Interleukin-7: A key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction

Current Pharmaceutical Design

Volumn 18, Issue 16, 2012, Pages 2347-2356

  Bikker, Angela ^a   Hack, C Erik ^a   Lafeber, Floris P J G ^a   van Roon, Joel A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoimmunity; IL 7; IL 7 receptor; Immunopathology; Inflammatory disorders; Macrophages; Rheumatic diseases; T cells

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; FIBROBLAST; INFLAMMATION; MACROPHAGE; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; STROMA CELL; TH1 CELL; TH17 CELL; TISSUE INJURY;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; GRAFT VS HOST DISEASE; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERLEUKIN-7; MODELS, ANIMAL; RECEPTORS, INTERLEUKIN-7; T-LYMPHOCYTES;

EID: 84860173708     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212800165979     Document Type: Article

References (109)

1. Pandey A, Ozaki K, Baumann H, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol 2000; 1: 59-64.
2. Sims JE, Williams DE, Morrissey PJ, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. The Journal of experimental medicine 2000; 192: 671-680.
3. Park LS, Martin U, Garka K, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. The Journal of experimental medicine 2000; 192: 659-670.
4. Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. The Journal of experimental medicine 2010; 207: 281-290.
5. Morgado R, Oliveira FA, Batrouni GG, Hansen A. Relation between anomalous and normal diffusion in systems with memory. Phys Rev Lett 2002; 89: 100601.
6. Reche PA, Soumelis V, Gorman DM, et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001; 167: 336-343.
7. Vasir B, Avigan D, Wu Z, et al. Dendritic cells induce MUC1 expression and polarization on human T cells by an IL-7-dependent mechanism. J Immunol 2005; 174: 2376-2386.
8. Sieling PA, Sakimura L, Uyemura K, et al. IL-7 in the cellmediated immune response to a human pathogen. J Immunol 1995; 154: 2775-2783.
9. Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-3904.
10. Goodwin RG, Lupton S, Schmierer A, et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989; 86: 302-306.
11. Giliani S, Mori L, de Saint Basile G, et al. Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunological reviews 2005; 203: 110-126.
12. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nature genetics 1998; 20: 394-397.
13. Chu YW, Memon SA, Sharrow SO, et al. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 2004; 104: 1110-1109.
14. Sempowski G, Thomasch J, Gooding M, et al. Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 2001; 166: 2808-2817.
15. Hakim FT, Memon SA, Cepeda R, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 2005; 115: 930-939.
16. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM. Interleukin 7 regulates the survival and generation of memory CD4 cells. The Journal of experimental medicine 2003; 198: 1797-1806.
17. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4: 680-686.
18. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011; 11: 330-342.
19. Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest 2005; 115: 1177-1187.
20. Carreno BM, Becker-Hapak M, Linette GP. CD40 regulates human dendritic cell-derived IL-7 production that, in turn, contributes to CD8(+) T-cell antigen-specific expansion. Immunol Cell Biol 2009; 87: 167-177.
21. Saini M, Pearson C, Seddon B. Regulation of T cell-dendritic cell interactions by IL-7 governs T-cell activation and homeostasis. Blood 2009; 113: 5793-5800.
22. Singh V, Gowthaman U, Jain S, et al. Coadministration of interleukins 7 and 15 with bacille Calmette-Guerin mounts enduring T cell memory response against Mycobacterium tuberculosis. J Infect Dis 2010; 202: 480-489.
23. Unsinger J, McGlynn M, Kasten KR, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010; 184: 3768-3779.
24. van Roon J, Wijngaarden S, Lafeber FP, Damen C, van de Winkel J, Bijlsma JW. Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation. The Journal of rheumatology 2003; 30: 648-651.
25. Girard D, Beaulieu AD. Absence of the IL-7 receptor component CDw127 indicates that gamma(c) expression alone is insufficient for IL-7 to modulate human neutrophil responses. Clinical immunology and immunopathology 1997; 83: 264-271.
26. Sportes C, Babb RR, Krumlauf MC, et al. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res 2010; 16: 727-735.
27. Li AL, Li C, Feng YG, et al. Antileukemic effect of interleukin-7- transduced bone marrow stromal cells in mice following allogeneic T-cell-depleted bone marrow transplantation. Transplant Proc 2005; 37: 2297-2299.
28. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996; 85: 307-310.
29. Roudier J. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection. Arthritis Res 2000; 2: 217-220.
30. Pellegrini M, Calzascia T, Elford AR, et al. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med 2009; 15: 528-536.
31. Chung B, Dudl EP, Min D, Barsky L, Smiley N, Weinberg KI. Prevention of graft-versus-host disease by anti IL-7Ralpha antibody. Blood 2007; 110: 2803-2810.
32. Wang Y, Dai H, Liu Z, Cheng X, Tellides G, Dai Z. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Am J Transplant 2006; 6: 2851-2860.
33. Moniuszko M, Fry T, Tsai WP, et al. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol 2004; 78: 9740-9749.
34. Storek J, Gillespy T, 3rd, Lu H, et al. Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys. Blood 2003; 101: 4209-4218.
35. Lu H, Zhao Z, Kalina T, et al. Interleukin-7 improves reconstitution of antiviral CD4 T cells. Clin Immunol 2005; 114: 30-41.
36. Parker R, Dutrieux J, Beq S, et al. Interleukin-7 treatment counteracts IFN-alpha therapy-induced lymphopenia and stimulates SIV-specific cytotoxic T lymphocyte responses in SIV-infected rhesus macaques. Blood 2010; 116: 5589-5599.
37. Sereti I, Dunham RM, Spritzler J, et al. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009; 113: 6304-6314.
38. Watanabe M, Ueno Y, Yajima T, et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. The Journal of experimental medicine 1998; 187: 389-402.
39. Yamazaki M, Yajima T, Tanabe M, et al. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J Immunol 2003; 171: 1556-1563.
40. Okada E, Yamazaki M, Tanabe M, et al. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. Am J Physiol Gastrointest Liver Physiol 2005; 288: G745-G754.
41. Watanabe M, Watanabe N, Iwao Y, et al. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. J Clin Immunol 1997; 17: 282-292.
42. Watanabe M, Ueno Y, Yajima T, et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 1995; 95: 2945-2953.
43. Hoe E, McKay FC, Schibeci SD, et al. Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. J Immunol. 184: 2512-2517.
44. Liu X, Leung S, Wang C, et al. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 2010; 16: 191-197.
45. Sawa S, Kamimura D, Jin GH, et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. The Journal of experimental medicine 2006; 203: 1459-1470.
46. Hartgring SA, van Roon JA, Wenting-van Wijk M, et al. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis and rheumatism 2009; 60: 2595-2605.
47. Hartgring SA, Willis CR, Bijlsma J, Lafeber F, Roon JV. IL-7 receptor ligands IL-7 and TSLP promote collagen-induced arthrithis, associated by differential T-cell activity and induction of proinflammatory mediators. Arthritis and rheumatism 2009; 60, suppl 10: 1091.
48. Tervahartiala T, Koski H, Xu JW, et al. Tumor necrosis factoralpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001; 80: 1535-1539.
49. Webb LM, Foxwell BM, Feldmann M. Putative role for interleukin-7 in the maintenance of the recirculating naive CD4+ Tcell pool. Immunology 1999; 98: 400-405.
50. Chou YK, Bourdette DN, Barnes D, et al. IL-7 enhances Agspecific human T cell response by increasing expression of IL-2R alpha and gamma chains. J Neuroimmunol 1999; 96: 101-111.
51. van Roon JA, Verweij MC, Wijk MW, Jacobs KM, Bijlsma JW, Lafeber FP. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis and rheumatism 2005; 52: 1700-1710.
52. Alderson MR, Tough TW, Ziegler SF, Grabstein KH. Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J experimental Med 1991; 173: 923-930.
53. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995; 154: 5093-5102.
54. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 107: 10961-10966.
55. Bui T, Dykers T, Hu SL, Faltynek CR, Ho RJ. Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cellmediated immune responses to a recombinant HIV-envelope protein. J Acquir Immune Defic Syndr 1994; 7: 799-806.
56. Standiford TJ, Strieter RM, Allen RM, Burdick MD, Kunkel SL. IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. J Immunol 1992; 149: 2035-2039.
57. Ziegler SF, Tough TW, Franklin TL, Armitage RJ, Alderson MR. Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaccharide and IL-7. J Immunol 1991; 147: 2234-2239.
58. van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Annals of the rheumatic diseases 2003; 62: 113-119.
59. Lundmark F, Duvefelt K, Iacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nature genetics 2007; 39: 1108-1113.
60. Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-celltargeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-2581.
61. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis and rheumatism 1997; 40: 5-18.
62. Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis and rheumatism 2000; 43: 617-627.
63. Namekawa T, Wagner UG, Goronzy JJ, Weyand CM. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis and rheumatism 1998; 41: 2108-2116.
64. Morita Y, Yamamura M, Kawashima M, et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis and rheumatism 1998; 41: 1669-1676.
65. Chabaud M, Durand JM, Buchs N, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and rheumatism 1999; 42: 963-970.
66. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144: 3347-3353.
67. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis and rheumatism 1996; 39: 115-124.
68. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004; 350: 2167-2179.
69. Kremer JM, Westhovens R, Leon M, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003; 349: 1907-1915.
70. Ponchel F, Verburg RJ, Bingham SJ, et al. Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis research & therapy 2005; 7: R80-R92.
71. de Benedetti F, Pignatti P, Massa M, Sartirana P, Ravelli A, Martini A. Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. Clinical and experimental rheumatology 1995; 13: 779-784.
72. Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis and rheumatism 2004; 50: 3663-3667.
73. Leistad L, Ostensen M, Faxvaag A. Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction. Scand J Rheumatol 1998; 27: 61-67.
74. Chizzolini C, Parel Y, Scheja A, Dayer JM. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts. Arthritis research & therapy 2006; 8: R10.
75. van Hamburg JP, Asmawidjaja PS, Davelaar N, et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis and rheumatism 2010; 63: 73-83.
76. Hartgring SAY, Willis CR, Broere F, et al. Blockade of the high affinity IL-7 receptor inhibits proteoglycan-induced arthritis. Arthritis and rheumatism 2008; 58: S844-S845.
77. Cope AP, Londei M, Chu NR, et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 1994; 94: 749-760.
78. Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997; 94: 9360-9365.
79. Hartgring SA, Bijlsma JW, Lafeber FP, van Roon JA. Interleukin-7 induced immunopathology in arthritis. Annals of the rheumatic diseases 2006; 65 Suppl 3: iii69-iii74.
80. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 2003; 100: 125-130.
81. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000; 96: 1873-1878.
82. van Eden W, van der Zee R, Taams LS, Prakken AB, van Roon J, Wauben MH. Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunological reviews 1998; 164: 169-174.
83. Sakkas LI, Scanzello C, Johanson N, et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clinical and diagnostic laboratory immunology 1998; 5: 430-437.
84. Maurice MM, van der Voort EA, Leow A, Levarht N, Breedveld FC, Verweij CL. CD28 co-stimulation is intact and contributes to prolonged ex vivo survival of hyporesponsive synovial fluid T cells in rheumatoid arthritis. European journal of immunology 1998; 28: 1554-1562.
85. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin- 15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996; 2: 175-182.
86. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 1997; 3: 189-195.
87. van Roon JA, Hartgring SA, Wenting-van Wijk M, et al. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. Annals of the rheumatic diseases 2007; 66: 664-669.
88. van Roon JA, Glaudemans CA, Bijlsma JW, Lafeber FP. Differentiation of naive CD4+ T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients. Arthritis research & therapy 2003; 5: R269-R276.
89. van Roon JA, van Roy JL, Duits A, Lafeber FP, Bijlsma JW. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Annals of the rheumatic diseases 1995; 54: 836-840.
90. Harada S, Yamamura M, Okamoto H, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis and rheumatism 1999; 42: 1508-1516.
91. Badot V, Durez P, Van den Eynde B, Nzeusseu-Toukap A, Houssiau F, Lauwerys B. Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines. J Cell Mol Med 2010.
92. Booth DR, Arthur AT, Teutsch SM, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med 2005; 83: 822-830.
93. Korte A, Kochling J, Badiali L, et al. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all. Cytokine 2000; 12: 1597-1608.
94. Carini C, McLane MF, Mayer KH, Essex M. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection. European journal of immunology 1994; 24: 2927-2934.
95. Ruprecht CR, Gattorno M, Ferlito F, et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. The Journal of experimental medicine 2005; 201: 1793-1803.
96. Bonifati C, Trento E, Cordiali-Fei P, et al. Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. Clinical immunology and immunopathology 1997; 83: 41-44.
97. Bikker A, van Woerkom JM, Kruize AA, et al. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. Arthritis and rheumatism. 62: 969-977.
98. van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, et al. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non-Sjogren's sicca syndrome. Annals of the rheumatic diseases 2005; 64: 1474-1479.
99. Bikker A, Kruize A, Wenting M, et al. IL-7 receptor positive effector T cells are increased in the inflamed salivary glands of pSS patients and correlate with glandular inflammation and IL-7 expression. Annals of the rheumatic diseases 2011; 70: A51.
100. Timmer TC, Baltus B, Vondenhoff M, et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis and rheumatism 2007; 56: 2492-2502.
101. Meier D, Bornmann C, Chappaz S, et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007; 26: 643-654.
102. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 2010; 328: 749-752.
103. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7: 1057-1062.
104. Hartgring SA, Willis CR, Alcorn D, et al. Blockade of the IL-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T-cell activity and proinflammatory mediators. Arthritis and rheumatism.
105. O'Doherty C, Alloza I, Rooney M, Vandenbroeck K. IL7RA polymorphisms and chronic inflammatory arthropathies. Tissue Antigens 2009; 74: 429-431.
106. Rihl M, Kellner H, Kellner W, et al. Identification of interleukin-7 as a candidate disease mediator in spondylarthritis. Arthritis and rheumatism 2008; 58: 3430-3435.
107. van Roon J, van Woerkom J, Bikker A, et al. editors. Increased IL- 7 expression in salivary glands of pSS patients correlates with immunopathology and drives TH1-associated immune responses 2008.
108. Li J, Huston G, Swain SL. IL-7 promotes the transition of CD4 effectors to persistent memory cells. The Journal of experimental medicine 2003; 198: 1807-1815.
109. Bebo BF, Jr., Schuster JC, Adlard K, Vandenbark AA, Offner H. Interleukin 7 is a potent co-stimulator of myelin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis. Cytokine 2000; 12: 324-331.